COVID vaccination has turned into a ‘battle of the brands’ – but not everyone’s buying it
In this cross posting from The Conversation Katie Attwell, The University of Western Australia; Lara McKenzie, The University of Western Australia, and Samantha Carlson, Telethon Kids Institute look at the impact of COVID-19 vaccine brands.
When we were hanging out for a COVID-19 vaccine in 2020, it was a bit like a horse race. We asked ourselves which vaccine would get over the line to win, and how quickly. Then, as multiple vaccines began reporting results from clinical trials, the race turned to which could offer superior efficacy and safety.
Flash forward to 2021, with multiple safe and effective vaccines approved, parts of the globe are experiencing “brand tribalism”. Which brand of vaccine you want, or can get, has become a hot issue.
In the United States, young vaccinators post their vaccine “team” or “tribe” preferences on social media, saying, “only hot people get the Pfizer Vaccine”.
